Wellgistics Health Secures $1.25M in Promissory Notes with 20% Discount Amidst Financial Distress

summarizeSummary

Wellgistics Health entered into an agreement to issue $1.25 million in promissory notes for $1 million, reflecting a 20% discount, to address its critical financial needs.

check_boxKey Events

• Secured $1.25M Promissory Notes

  The company entered a Note Purchase Agreement on April 1, 2026, to issue up to $1.25 million in aggregate principal amount of promissory notes to certain investors.

• 20% Original Issue Discount

  Investors paid an aggregate purchase price of $1 million for the $1.25 million in notes, reflecting a 20% original issue discount.

• Restrictive Covenants Imposed

  The agreement includes covenants preventing the company from incurring additional borrowed money debt or granting new liens on assets while the notes are outstanding.

• Investor Participation and Conversion Rights

  Noteholders have the right to participate in future equity offerings and can convert their outstanding principal into securities of a future offering or demand cash repayment.

auto_awesomeAnalysis

This financing is critical for Wellgistics Health, a company facing a going concern warning and Nasdaq delisting. While it provides much-needed capital, the terms are highly unfavorable, reflecting the company's distressed state. The 20% original issue discount means the company receives only $1 million for $1.25 million in debt. The restrictive covenants on future debt and liens, coupled with investor participation rights in future equity offerings, indicate a significant concession to secure this funding. This transaction follows recent news of the offering and a finalized reverse stock split, underscoring the urgent need for capital to address liquidity and compliance issues.